Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Thymalin Dosage Chart - Peptide Dosages

Thymalin (10 mg) Dosage Protocol A thymic peptide bioregulator studied for immune modulation and healthy aging — decades of Russian clinical use, but not an FDA-approved drug. Immunomodulatory thymic peptide complex — studied to help restore age-weakened T-cel

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Thymalin (10 mg) Dosage Protocol

A thymic peptide bioregulator studied for immune modulation and healthy aging — decades of Russian clinical use, but not an FDA-approved drug.

Immunomodulatory thymic peptide complex — studied to help restore age-weakened T-cell balance and immune function.

Short injectable course: 5–10 mg once daily for 5–10 days, repeated 1–2× a year rather than taken continuously.

Bioregulator with decades of Russian/Eastern-European clinical use; no independent Western trials and not FDA-approved.

Quickstart Highlights

Thymalin is a thymic peptide preparation — a complex of short polypeptides extracted from calf thymus and one of the original “peptide bioregulators” developed by Vladimir Khavinson and colleagues at the St. Petersburg Institute of Bioregulation and Gerontology[2]. In the published research it is studied for immune modulation — the idea of restoring age-weakened thymic and T-cell function — and it is dosed as a short injectable course rather than daily and indefinitely[1].

Almost all of the human clinical evidence for Thymalin comes from Russian and Eastern-European studies and has not been independently replicated in large Western trials; it is a registered drug in Russia/CIS but is not approved by the FDA. The figures below reflect those published research conventions and are provided strictly for research and educational reference — not medical advice. Grey-market “thymalin” is an animal-derived extract of unverifiable content and purity.

Mix & measure Thymalin · 10 mg

Pre-filled with this protocol’s recommended BAC water and documented starting dose — edit any field to run your own numbers.

Reconstitution math only — not dosing advice. U-100 syringe: 100 units = 1 mL. Full reconstitution guide → · Advanced calculator →

Supplies Needed

Everything a documented injectable course relies on. Nothing here is exotic — sterile technique and accurate measurement matter far more than any single tool.

Protocol Overview

At 5 mg/mL a single 10 mg vial holds 2 mL of usable solution — two days at a 5 mg daily dose, or one day at the full 10 mg. A standard 5–10 day course therefore needs several vials; plan supply around the course length rather than assuming one vial covers it.

Because Thymalin is course-based, there is no ongoing daily maintenance dose in the research — the protocol is a defined run of injections followed by a break of several months before any repeat course.

Dosing Protocol

A reference course converted to U-100 units at 5 mg/mL. This mirrors the short-course structure used in the published Russian protocols; it is not a titration and not clinical guidance.

Lighter course (days 1–10)

5 mg once daily

100 units (1.00 mL)

Standard course (days 1–10)

10 mg once daily

200 units (2.00 mL, full vial)

Between courses

No dosing

Repeat 1–2× per year only

Why Thymalin draws research interest

These are the directions researchers and the peptide community most often explore Thymalin for — so you know you’re in the right place. They describe what is being studied, not proven benefits, approved uses, or promised results.

Immune support

Studied to normalize T-cell balance and immune indices in aged or immunocompromised states — the core rationale for thymic peptides.

Fewer respiratory infections

A multi-year elderly cohort reported markedly lower acute-respiratory-disease incidence during Thymalin courses versus control.

Geroprotective interest

Russian studies reported reduced age-related disease and mortality — a striking claim that has not been independently replicated, to read cautiously.

Evidence ranges from early laboratory work to clinical trials depending on the use — the sections below cover the actual data and sources.

Add 2.0 mL bacteriostatic water to one 10 mg vial → 5 mg/mL (5,000 mcg/mL).

Reference course 5–10 mg once daily for 5–10 days; courses repeated 1–2× per year, not taken continuously.

Intramuscular or subcutaneous, once daily, commonly in the morning; rotate sites.

Bioregulator — Russian clinical data only; decades of Eastern-European use but no independent Western trials and no FDA approval.

Dosing & Reconstitution Guide

Unlike a continuously-dosed peptide, Thymalin in the literature is a course-based agent: a defined number of daily injections, then a break. The classic Russian protocols keep each course short and repeat it periodically rather than dosing every day year-round.

Standard / Gradual Approach

The reference approach is a fixed short course rather than a slow titration: 5 to 10 mg once daily for 5 to 10 consecutive days makes up one course, after which dosing stops and the course may be repeated once or twice a year[1]. Reconstituted at 5 mg/mL, a 5 mg dose equals 1.0 mL (100 units on a U-100 syringe) and a 10 mg dose equals the full 2.0 mL vial. Many research users work at the lower 5 mg end so a single vial covers two days.

Reconstitution Steps

Reconstitution is standard for a lyophilized peptide — a modest diluent volume keeps a 10 mg vial physically sensible and easy to measure.

▪Sanitize: Swab the vial stopper and the bacteriostatic-water vial with fresh alcohol pads and let them dry.

▪Add diluent slowly: Draw 2.0 mL bacteriostatic water and let it run down the inside wall of the vial — do not spray it directly onto the powder.

▪Dissolve gently: Swirl; do not shake. The solution should clear within a minute or two.

▪Store: Label with the date and refrigerate at 2–8 °C; the reconstituted vial holds ~5 mg/mL.

Storage Instructions

Store the lyophilized vial in the freezer or refrigerator away from light until reconstitution.

After reconstitution, keep the vial refrigerated at 2–8 °C and use within the bacteriostatic-water window (commonly cited as up to ~28 days). Discard if the solution becomes cloudy or discolored.

Important Notes

Practical points that keep a short injectable course consistent and honest about what the compound is.

▪Course, not continuous: The research uses short courses with long breaks — there is no basis for taking Thymalin every day indefinitely.

▪Animal-derived extract: Thymalin is a bovine thymus peptide fraction, not a single defined molecule; grey-market composition and purity cannot be verified without a Certificate of Analysis.

▪Sterile technique: Fresh U-100 syringe each injection, straight into a puncture-proof sharps container afterward.

▪Evidence caveat: Efficacy claims rest almost entirely on Russian/Eastern-European studies from a single research group and have not been confirmed by independent Western trials[1]; it is not FDA-approved. Treat immune and longevity claims as unproven.

How This Works

Thymalin is described as an immunomodulatory thymic peptide complex: the thymus produces peptide signals that guide the maturation and balance of T-lymphocytes, and thymic output declines steeply with age (thymic involution). Thymalin is studied as a way to help normalize T-cell parameters and immune balance in aged or immunocompromised states[2].

In the broader “peptide bioregulator” framework proposed by the Khavinson group, short peptides are thought to act at the level of gene expression — modulating transcription of factors tied to inflammation, senescence and tissue-specific function — which is the mechanistic rationale offered for both the immune and the geroprotective effects reported for thymic peptides[4]. This model is compelling but remains largely outside independently-replicated human evidence.

Lifestyle Factors

Because the reported role of Thymalin is immune support rather than a metabolic or performance effect, the surrounding habits that matter most are the ordinary ones — adequate sleep, nutrition and management of chronic stress, all of which independently affect immune function.

As a course-based agent, it is typically studied against a backdrop of general health maintenance rather than as a standalone intervention; nothing about it removes the need for standard preventive care and vaccination where appropriate.

Potential Benefits & Side Effects

What the published (predominantly Russian) literature reports; this is not equivalent to a supervised, independently-validated therapy, the trials were conducted by a small number of groups, and individual outcomes vary.

Reported Effects

▪Immune normalization: Thymic peptide preparations are reported to help restore T-cell balance and immune indices in aged and immunocompromised subjects[2].

▪Fewer respiratory infections: In a long-term elderly cohort, Thymalin was associated with a 2.0–2.4-fold lower incidence of acute respiratory disease versus control[1].

▪Geroprotective signal: The same multi-year study reported reduced mortality in Thymalin-treated elderly groups — a striking claim that has not been independently reproduced and should be read cautiously[3].

▪Course tolerability: Short injectable courses were generally reported as well tolerated in these studies.

Common Side Effects

▪Injection-site reactions: Local redness, soreness or swelling are the most predictable effects of any IM/SC injection.

▪Allergic potential: As an animal-derived (bovine) protein extract, hypersensitivity is a theoretical risk — a genuine caution for any biological preparation.

▪Unverified purity: Grey-market extracts vary; contaminants or mislabeling are the practical safety concern rather than a well-characterized pharmacologic toxicity.

▪Unknowns: Long-term safety outside the Russian literature is not established, and immune-modulating agents warrant caution in autoimmune conditions.

Injection Technique

Intramuscular or subcutaneous injection technique is standard. Accuracy and site rotation matter more than speed.

Pre-Injection Preparation

▪Wash hands; let the refrigerated vial come toward room temperature to reduce sting.

▪Swab the stopper and injection site; let the alcohol dry fully.

▪Draw your course dose into a fresh U-100 syringe and tap out air bubbles.

Injection Procedure

▪For SC, pinch a skinfold (abdomen or thigh) and insert at 45–90°; for IM, inject into a large muscle (e.g. deltoid or gluteal) at 90°.

▪Inject the solution at a steady, even pace.

▪Withdraw and apply light pressure with a clean swab — do not rub.

Post-Injection Care

▪Drop the used syringe straight into a puncture-proof sharps container.

▪Rotate sites day to day across the course to avoid local irritation.

▪Return the vial to the refrigerator promptly.

Recommended Source

For high-purity research peptides, we point researchers to Prime Lab Peptides for Thymalin (10 mg Vial).

Why Prime Lab Peptides?

▪Top-rated on Trustpilot: Independently reviewed as the highest-rated peptide lab on Trustpilot — making it the best current source in the USA.

▪Third-party tested: Every batch ships with a Certificate of Analysis (COA) confirming purity and composition.

▪Consistent quality: ISO-aligned manufacturing and handling keep product integrity reliable batch to batch.

▪Cold-chain integrity: Temperature-controlled shipping and storage across the whole fulfilment chain.

▪Research-grade purity: Fit for educational and research use that demands high-quality peptides.

Note: Product availability and specifications subject to change. Verify current product details on supplier website.

References

View Source ↗

Thymalin — frequently asked questions

Wipe the stopper with an alcohol swab, then inject your bacteriostatic water slowly down the inside wall of the vial. Let it sit and gently swirl until dissolved — never shake. Store the mixed vial in the refrigerator and draw doses with an insulin syringe. Use the calculator above to turn any dose into syringe units.

There is no single correct amount — more water simply spreads the same 10 mg of peptide across a larger volume, which makes small doses easier to measure accurately. 1 to 3 mL per vial is typical. Enter your chosen volume in the calculator above to see the resulting concentration and syringe units.

On a U-100 insulin syringe, 100 units equal 1 mL, so 1 unit equals 0.01 mL. The calculator above converts your draw volume into these units automatically so you can measure without doing the math by hand.

Keep the reconstituted vial refrigerated at roughly 2 to 8 degrees Celsius, away from light, and avoid freezing it. Reconstituted research peptides are generally used within a few weeks. Always follow the specific guidance supplied with your product.

Divide the vial strength of 10 mg by the amount you use per injection. The calculator above reports this as "doses per vial" the moment you enter a dose.

No. Thymalin is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use. Everything on this page is research information, not medical advice — consult a licensed healthcare professional before any use.

New protocols & dosing updates

Reconstitution charts, new peptide protocols and safety updates — straight to your inbox. No spam, unsubscribe anytime.

Written by Dr. Aimen Arij, PharmD

Related Immune & Gut protocols

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Related questions

01Retinalamin — frequently asked questions

Wipe the stopper with an alcohol swab, then inject your bacteriostatic water slowly down the inside wall of the vial. Let it sit and gently swirl until dissolved — never shake. Store the mixed vial in the refrigerator and draw doses with an insulin syringe. Use the calculator above to turn any dose into syringe units. There is no single correct amount — more water simply spreads the same 5 mg of peptide across a larger volume, which makes small doses easier to measure accurately. 1 to 3 mL per vial is typical. Enter your chosen volume in the calculator above to see the resulting concentration and syringe units. On a U-100 insulin syringe, 100 units equal 1 mL, so 1 unit equals 0.01 mL. The calculator above converts your draw volume into these units automatically so you can measure without doing the math by hand. Keep the reconstituted vial refrigerated at roughly 2 to 8 degrees Celsius, away from light, and avoid freezing it. Reconstituted research peptides are generally used within a few weeks. Always follow the specific guidance supplied with your product. Divide the vial strength of 5 mg by the amount you use per injection. The calculator above reports this as "doses per vial" the moment you enter a dose. No. Retinalamin is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use. Everything on this page is research information, not medical advice — consult a licensed healthcare professional before any use.

Source: dosagepeptide.com ↗
02What If My Reconstituted Thymalin Was Left Out of the Fridge Overnight?

Discard the vial. Thymalin's peptide structure denatures at ambient temperature (20–25°C) within 6–8 hours, and the degradation is irreversible. The solution may still appear clear and colorless, but protein denaturation destroys binding affinity to thymic receptors. Injecting degraded peptide produces no thymic stimulation. This is not a minor potency loss; it's complete inactivation. Temperature-sensitive peptides require uncompromising cold chain discipline.

Source: realpeptides.co ↗
03Davunetide — frequently asked questions

Wipe the stopper with an alcohol swab, then inject your bacteriostatic water slowly down the inside wall of the vial. Let it sit and gently swirl until dissolved — never shake. Store the mixed vial in the refrigerator and draw doses with an insulin syringe. Use the calculator above to turn any dose into syringe units. There is no single correct amount — more water simply spreads the same 5 mg of peptide across a larger volume, which makes small doses easier to measure accurately. 1 to 3 mL per vial is typical. Enter your chosen volume in the calculator above to see the resulting concentration and syringe units. On a U-100 insulin syringe, 100 units equal 1 mL, so 1 unit equals 0.01 mL. The calculator above converts your draw volume into these units automatically so you can measure without doing the math by hand. Keep the reconstituted vial refrigerated at roughly 2 to 8 degrees Celsius, away from light, and avoid freezing it. Reconstituted research peptides are generally used within a few weeks. Always follow the specific guidance supplied with your product. Divide the vial strength of 5 mg by the amount you use per injection. The calculator above reports this as "doses per vial" the moment you enter a dose. No. Davunetide is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use. Everything on this page is research information, not medical advice — consult a licensed healthcare professional before any use.

Source: dosagepeptide.com ↗
04Cortexin — frequently asked questions

Wipe the stopper with an alcohol swab, then inject your bacteriostatic water slowly down the inside wall of the vial. Let it sit and gently swirl until dissolved — never shake. Store the mixed vial in the refrigerator and draw doses with an insulin syringe. Use the calculator above to turn any dose into syringe units. There is no single correct amount — more water simply spreads the same 10 mg of peptide across a larger volume, which makes small doses easier to measure accurately. 1 to 3 mL per vial is typical. Enter your chosen volume in the calculator above to see the resulting concentration and syringe units. On a U-100 insulin syringe, 100 units equal 1 mL, so 1 unit equals 0.01 mL. The calculator above converts your draw volume into these units automatically so you can measure without doing the math by hand. Keep the reconstituted vial refrigerated at roughly 2 to 8 degrees Celsius, away from light, and avoid freezing it. Reconstituted research peptides are generally used within a few weeks. Always follow the specific guidance supplied with your product. Divide the vial strength of 10 mg by the amount you use per injection. The calculator above reports this as "doses per vial" the moment you enter a dose. No. Cortexin is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use. Everything on this page is research information, not medical advice — consult a licensed healthcare professional before any use.

Source: dosagepeptide.com ↗
05Teduglutide — frequently asked questions

Wipe the stopper with an alcohol swab, then inject your bacteriostatic water slowly down the inside wall of the vial. Let it sit and gently swirl until dissolved — never shake. Store the mixed vial in the refrigerator and draw doses with an insulin syringe. Use the calculator above to turn any dose into syringe units. There is no single correct amount — more water simply spreads the same 5 mg of peptide across a larger volume, which makes small doses easier to measure accurately. 1 to 3 mL per vial is typical. Enter your chosen volume in the calculator above to see the resulting concentration and syringe units. On a U-100 insulin syringe, 100 units equal 1 mL, so 1 unit equals 0.01 mL. The calculator above converts your draw volume into these units automatically so you can measure without doing the math by hand. Keep the reconstituted vial refrigerated at roughly 2 to 8 degrees Celsius, away from light, and avoid freezing it. Reconstituted research peptides are generally used within a few weeks. Always follow the specific guidance supplied with your product. Divide the vial strength of 5 mg by the amount you use per injection. The calculator above reports this as "doses per vial" the moment you enter a dose. No. Teduglutide is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use. Everything on this page is research information, not medical advice — consult a licensed healthcare professional before any use.

Source: dosagepeptide.com ↗
Research context

Read sources and limitations before applying a claim.

Safety and Tolerability in the Research Setting

Safety and efficacy are separate questions, and it is entirely possible for a compound to be well tolerated while remaining unproven for the condition of interest. That is the current situation for NAD+ precursors in Parkinson’s disease. The short-term tolerability data, particularly for oral nicotinamide riboside, are reassuring within the limits of the trials conducted, but they are not a statement about long-term safety, about frail or elderly populations over years, or about drug interactions in people taking multiple Parkinson’s medications. The most directly relevant safety dataset is NR-SAFE, which was explicitly designed to probe tolerability at a high dose. Over four weeks, 3,000 mg of NR daily produced only mild adverse events, with no moderate or severe events and no significant excess over placebo; the most frequently reported events in the NR arm included extrapyramidal symptoms, headache, tremor, muscle cramps, fatigue, nausea, and dyspepsia, several of which overlap with the underlying disease and its treatment.2 The absence of painful flushing is notable because flushing is a classic dose-limiting effect of nicotinic acid (niacin); NR and nicotinamide generally avoid the flushing that niacin causes, which is one reason they are favored for chronic dosing. The lower-dose NADPARK trial similarly reported that 1,000 mg daily was well tolerated over 30 days.1 Broader supplement-safety literature on NR in non-Parkinson populations has generally supported tolerability at commonly studied doses, and NMN has likewise been reported to raise blood NAD+ safely in short studies of healthy adults.13 These reassurances come with substantial caveats that a careful reader should hold in mind. First, the trials are small and short. Twenty participants over four weeks, or thirty over one month, cannot detect uncommon adverse events or effects that only emerge with months to years of exposure, which is exactly the exposure that disease modification would require. Second, the populations were selected: early-stage, often newly diagnosed patients able to participate in a trial, not the full spectrum of advanced disease, multimorbidity, and polypharmacy seen in practice. Third, theoretical concerns exist that have not been resolved in humans. Because NAD+ metabolism intersects with cell proliferation and with the kynurenine pathway, and because some preclinical work has raised tissue-specific concerns about chronic high-dose precursor exposure (for example, questions about metabolite accumulation with sustained oral NMN in animal models), long-term safety cannot be assumed from short-term tolerability.13 Fourth, methylation load is a plausible consideration: clearance of excess nicotinamide consumes methyl groups, and the metabolic consequences of chronically high precursor intake over years are not well characterized in this population. There is also the matter of source and quality. In a research context, the identity, purity, and endotoxin status of a compound materially affect both the validity of an experiment and the safety of any handling. Injectable NAD+ preparations used outside regulated trials vary widely in provenance, and intravenous NAD+ administration in particular has been associated with infusion-related discomfort (nausea, chest tightness, flushing) that is typically managed by slowing the infusion rate but underscores that route and formulation matter.4 None of this constitutes clinical guidance. The appropriate summary is that oral NR appears well tolerated in the short term at the doses tested in early Parkinson’s trials, that other precursors and routes have thinner safety records, and that long-term safety in Parkinson’s disease specifically remains unestablished pending completed, published, adequately long trials.

Source: dosagepeptide.com ↗

Why Dermorphin draws research interest

These are the directions researchers and the peptide community most often explore Dermorphin for — so you know you’re in the right place. They describe what is being studied, not proven benefits, approved uses, or promised results.

Source: dosagepeptide.com ↗
Practical and safety references

These excerpts are educational, not personalised medical instructions.

How-to reference

How to Read the 3% to 10% SNAP-8 Range

The ingredient developer supplied SNAP-8 as a preserved aqueous blend containing approximately 0.05% acetyl octapeptide-3. Adding 3% to 10% of that solution gives 0.0015% to 0.005% actual peptide in the final product[6]. A raw 10 mg vial and a preserved commercial premix are not operationally interchangeable. 3% 0.05% 0.0015% 6% 0.0030% 10% 0.0050%

Source: peptidedosages.com ↗
Dosage reference

Thymalin Dosage, Reconstitution & Mixing Trends

Explore Thymalin dosage trends, reconstitution volumes, and vial size patterns from anonymized WPA peptide calculator sessions. Thymalin is a multi-peptide thymic extract developed at the St. Petersburg Institute of Bioregulation under Morozov and Khavinson in the 1970s-1980s — the original Khavinson cytomedine-class compound and the conceptual predecessor of the synthetic short-peptide bioregulator family that followed. This data shows the dose amounts, vial sizes, and diluent volumes researchers most commonly select when reconstituting Thymalin. 3 Thymalin reconstitution calculations have been logged by the WPA community. The most common dose entered is 10mg (2 calculations). The most common bacteriostatic water volume is 5mL. The most popular vial size is 10mg (2 sessions). The most common dosing frequency is daily (7x/week) (1 logged protocols). World Peptide Association aggregates anonymized peptide calculator data to show real-world dosing trends, reconstitution volumes, and vial size preferences across the research peptide community. All figures shown are aggregated from anonymized calculator inputs and are provided strictly for independent laboratory research and educational purposes. They are community usage statistics — not dosing recommendations, and not medical advice.

Source: worldpeptideassociation.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →